
Dr Alex Menys
Founder and Chief Executive Officer
Alex founded Motilent in 2013 to expedite collaborative research in his field of medical image analysis for gastrointestinal (GI) disorders. Since then, Motilent has grown to working across a range of GI specialties in research and has produced it’s first clinically available product for Crohn’s disease monitoring – GIQuant. Alex holds master degrees in Biochemistry and Medical Physics, a PhD in MRI imaging and spent 2 years on the board of an AIM listed UK medical device company.